https://wikem.org/w/index.php?action=history&feed=atom&title=Pseudoephedrine 2026-04-19T05:50:13Z Revision history for this page on the wiki MediaWiki 1.38.2 https://wikem.org/w/index.php?title=Pseudoephedrine&diff=339090&oldid=prev 2022-02-08T18:49:34Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="es"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Revisión anterior</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revisión del 18:49 8 feb 2022</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Línea 1:</td> <td colspan="2" class="diff-lineno">Línea 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Administration==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Administration==</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*Type: Decongestant, [[sympathomimetic]]</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*Type: <ins style="font-weight: bold; text-decoration: none;">[[</ins>Decongestant<ins style="font-weight: bold; text-decoration: none;">]]</ins>, [[sympathomimetic]]</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Dosage Forms:</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Dosage Forms:</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Routes of Administration: PO</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*Routes of Administration: PO</div></td></tr> </table>

Rossdonaldson1 https://wikem.org/w/index.php?title=Pseudoephedrine&diff=226834&oldid=prev 2019-09-01T23:32:30Z

<p>Created page with &quot;==Administration== *Type: Decongestant, <a href="/wiki/Sympathomimetic" class="mw-redirect" title="Sympathomimetic">sympathomimetic</a> *Dosage Forms: *Routes of Administration: PO *Common Trade Names: Sudafed, Nexafed, Zephrex-D ==Adult Dosing== *Na...&quot;</p> <p><b>Página nueva</b></p><div>==Administration==<br /> *Type: Decongestant, [[sympathomimetic]]<br /> *Dosage Forms:<br /> *Routes of Administration: PO<br /> *Common Trade Names: Sudafed, Nexafed, Zephrex-D<br /> <br /> ==Adult Dosing==<br /> *Nasal congestion: 60mg PO q4-6h PRN<br /> *[[Priapism]]: 60-120mg PO once<br /> <br /> ==Pediatric Dosing==<br /> *&lt;2y: safety/efficacy not established<br /> *2-6y: 5-30mg PO q4-6h PRN<br /> *6-12y: 30mg PO q4-6h PRN OR 4mg/kg/day divided q6h<br /> *&gt;12y: 60mg PO q4-6h PR<br /> <br /> ==Special Populations==<br /> ===[[Drug pregnancy categories|Pregnancy Rating]]===<br /> *Pregnancy Category C, avoid use in first trimester<br /> <br /> ===Lactation risk===<br /> *Excreted in breast milk; irritability reported in nursing infants (limited data)&lt;ref&gt;https://reference.medscape.com/drug/sudafed-nexafed-pseudoephedrine-343412#6&lt;/ref&gt;<br /> <br /> ===Renal Dosing===<br /> *Caution with renal impairment<br /> <br /> ===Hepatic Dosing===<br /> *<br /> <br /> ==Contraindications==<br /> *Allergy to class/drug<br /> *Concomitant or recent (&lt;14d) MAOI use<br /> *Severe hypertension<br /> *Severe CAD<br /> *Caution with:<br /> **Mild/moderate hypertension, cardiac disease<br /> **Hyperthyroidism<br /> **Hyperglycemia, DM<br /> **Renal impairment<br /> **Seizure disorder<br /> **Glaucoma <br /> <br /> ==Adverse Reactions==<br /> ===Serious===<br /> *MI<br /> *Afib<br /> *Ischemic colitis<br /> <br /> ===Common===<br /> *Tremor, restlessness, insomnia<br /> *Nausea/vomiting<br /> *Hypertension<br /> *PVCs<br /> <br /> ==Pharmacology==<br /> *Half-life: 3-16h<br /> *Metabolism: Liver<br /> *Excretion: Urinary<br /> <br /> ==Mechanism of Action==<br /> *Alpha adrenergic agonist, causes vasoconstriction in nasal/respiratory mucosa. Also stimulates beta adrenergic receptors causing bronchial relaxation<br /> <br /> ==Comments==<br /> <br /> <br /> ==See Also==<br /> *[[URI]]<br /> <br /> ==References==<br /> &lt;references/&gt;<br /> <br /> [[Category:Pharmacology]]</div>

ClaireLewis